PharmaBlock has opened a new R&D facility in Pennsylvania, expanding its capacity to deliver GMP projects.PharmaBlock, a contract development and manufacturing organization focused on innovative chemistry and low-carbon manufacturing, announced on March 27, 2023 the opening of its new R&D facility i
March 27, 2023PharmaBlock (stock code: 300725.SZSE), a global, fully integrated CDMO company focused on innovative chemistry and low-carbon manufacturing, announces the opening of its new R&D facility in West Chester, Pennsylvania. The facility expands the company's footprint in the US and enables m
When it comes to business sustainability, our initial thoughts often revolve around improving organization efficiency, improving financial performance, and implementing a carbon reduction strategy. However, in the UN’s SDGs (Sustainable Development Goals), the intergovernmental organization has reco
Green Chemistry Awards to Bristol Myers Squibb, Merck & Co., and PharmaBlock Sciences
NANJING, China, March 28, 2023 /PRNewswire/ -- PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CDMO company focusing on innovative chemistry and low-carbon manufacturing, announced today that it has been selected as the winner of the 2023 CMO Excellence in Green Chemistry Award by
PharmaBlock Sciences：Making Waves in the Pharma Industry with Green ChemistryPharmaBlock Sciences is at the vanguard of implementing green chemistry processes, which has emerged as a crucial movement in the pharma industry’s ongoing commitment to promote sustainability, environmental responsibility,
Originally published on here.Article written by: Rock MullinPharmaBlock, a pharmaceutical research and manufacturing services firm, has opened an R&D site in West Chester, Pennsylvania. With 2,800 m2 of laboratory space, the facility includes process and analytical labs, as well as manufacturing sui